- Home
- ESTA vs ABSI Comparison
ESTA vs ABSI Comparison
Compare ESTA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESTA | ABSI |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.4B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ESTA | ABSI |
|---|---|---|
| Price | $61.99 | $10.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $98.00 | $14.82 |
| AVG Volume (30 Days) | 467.3K | ★ 4.0M |
| Earning Date | 10-29-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | 10.64 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,208,000.00 | $4,534,000.00 |
| Revenue This Year | $30.22 | $39.03 |
| Revenue Next Year | $24.46 | $310.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $47.23 | $2.24 |
| 52 Week High | $97.59 | $12.54 |
Technical Indicators
Market Signals| Indicator | ESTA | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 50.18 |
| Support Level | $54.10 | $8.15 |
| Resistance Level | $67.75 | $10.03 |
| Average True Range (ATR) | 3.93 | 0.94 |
| MACD | 0.63 | 0.16 |
| Stochastic Oscillator | 41.24 | 41.02 |
Price Performance
Historical ComparisonAbout ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.